谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Safety and Efficacy of High-Dose Leukocytapheresis in Patients with Refractory Asthma.

Tamotsu Ishizuka,Takeshi Hisada,Motoaki Hatori,Akio Koike,Kikuo Hanabuchi,Shinichi Matsuzaki,Yosuke Kamide,Mitsuyoshi Utsugi,Haruka Aoki,Reiko Yoshino,Noriko Yanagitani,Yasuhiko Koga,Akihiro Ono,Kyoichi Kaira,Noriaki Sunaga,Kunio Dobashi,Takahiro Tsuburai,Kazuo Akiyama,Masanobu Yamada,Kazuhiro Suzuki,Masatomo Mori

Inflammation research（2014）

引用 1|浏览13
暂无评分
摘要
An open-label, non-randomized, single-arm study was performed to investigate the safety and efficacy of high-dose leukocytapheresis (pulse LCAP) for refractory asthma.
更多
查看译文
关键词
Refractory asthma,Leukocytapheresis (LCAP),Peak expiratory flow rate (PEFR),Asthma control test (ACT),Fraction of exhaled nitric oxide (FeNO)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要